CAMBRIDGE MOLECULAR DIAGNOSTICS LTD

09600771
Active Cambridge

Research and experimental development on biotechnology

6 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
C

CAMBRIDGE MOLECULAR DIAGNOSTICS LTD

09600771

Research and experimental development on biotechnology

Founded 20 May 2015 Active Cambridge, England 6 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 25 Jun 2026 Next due 30 Sept 2026 2 months remaining
Confirmation Submitted 17 May 2026 Next due 3 Mar 2027 7 months remaining
Net assets £2M £9K 2024 year on year
Total assets £3M £305K 2024 year on year
Total Liabilities £358K £314K 2024 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

25 Science Park, Bio-Innovation Centre Milton Road Cambridge CB4 0FW England

Telephone

0800 000 0000

Website

www.example.com

Full company profile for CAMBRIDGE MOLECULAR DIAGNOSTICS LTD (09600771), an active life sciences and medical technology company based in Cambridge, England. Incorporated 20 May 2015. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type total-exemption-full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 2 months remaining

Net Assets, Total Assets & Total Liabilities (2016–2024)

Cash in Bank

£39.98k

Decreased by £378.87k (-90%)

Net Assets

£2.29M

Decreased by £8.93k (-0%)

Total Liabilities

£357.62k

Increased by £313.65k (+713%)

Turnover

N/A

Employees

6

Decreased by 2 (-25%)

Debt Ratio

13%

Increased by 11 (+550%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2024
31 Jan Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (1)

Investor NameInvestor SinceParticipating Rounds
Investor 1Nov 2023Bridge/Convertible

Share Capital

Share Capital

Share allotments and capital structure

17 Allotments 30,723 Shares £3.71m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
21 Aug 202517,507£250k£250k
10 Feb 20258,561£123k£14.314
15 Oct 202469£10k£143.49
15 Oct 2024195£28k£142.81
15 Oct 2024692£99k£143.08

Officers

Officers

2 active 1 resigned
Status
Kinane, Denis FrancisDirectorBritishScotland6920 Jun 2022Active
Reencara LimitedCorporate-directorUnknownUnknown4 Jun 2024Active

Shareholders

Shareholders (23)

Cotterford Co
42.4%
13,535
Prof. Denis Kinane
28.7%
9,163

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Gustavo Cerda Moya

Chilean

Active
Notified 6 Apr 2016
Residence England
DOB October 1980
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Cotterford Company Limited

Unknown

Active
Notified 1 May 2026
Nature of Control
  • Ownership Of Shares 50 To 75 Percent
  • Voting Rights 50 To 75 Percent

Group Structure

Group Structure

CAMBRIDGE MOLECULAR DIAGNOSTICS LTD Current Company

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
25 Jun 2026AccountsAnnual accounts made up to 31 Dec 2025
17 May 2026Persons With Significant ControlCotterford Company Limited notified as a person with significant control
17 May 2026Confirmation StatementConfirmation statement made on 17 Feb 2026 with updates
12 Feb 2026MortgageMortgage Create With Deed With Charge Number Charge Creation Date
10 Feb 2026OfficersTermination of Benjamin Fraser Adam Shaw as director on 1 Nov 2025
25 Jun 2026 Accounts

Annual accounts made up to 31 Dec 2025

17 May 2026 Persons With Significant Control

Cotterford Company Limited notified as a person with significant control

17 May 2026 Confirmation Statement

Confirmation statement made on 17 Feb 2026 with updates

12 Feb 2026 Mortgage

Mortgage Create With Deed With Charge Number Charge Creation Date

10 Feb 2026 Officers

Termination of Benjamin Fraser Adam Shaw as director on 1 Nov 2025

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2025

1 weeks ago on 25 Jun 2026

Cotterford Company Limited notified as a person with significant control

1 months ago on 17 May 2026

Confirmation statement made on 17 Feb 2026 with updates

1 months ago on 17 May 2026

Mortgage Create With Deed With Charge Number Charge Creation Date

4 months ago on 12 Feb 2026

Termination of Benjamin Fraser Adam Shaw as director on 1 Nov 2025

4 months ago on 10 Feb 2026